ATP8B4 Antibody [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05855IR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ATP8B4 Antibody [DyLight 755]
Immunogen
Produced in rabbits immunized with E. coli-derived Human ATP8B4 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ATP8B4 Antibody [DyLight 755]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ATP8B4
Alternate Names
ATPase class I type 8B member 4, ATPase, class I, type 8B, member 4, ATPIM, EC 3.6.3, EC 3.6.3.1, FLJ25418, KIAA1939, potential phospholipid-transporting ATPase IM, probable phospholipid-transporting ATPase IM
Gene Symbol
ATP8B4
Additional ATP8B4 Products
Product Documents for ATP8B4 Antibody [DyLight 755]
Product Specific Notices for ATP8B4 Antibody [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...